财务
- Market Capitalization 1.8 B
- Employee 260
- Founded 1997
- CEO N/A
- Website www.xencor.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG4W0
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-12.35
市销率
9.05
相关股票代码
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2021 | VIR Vir Biotechnology, Inc. - Common Stock | 10.48 USD | +0.67% | -2.78% | -0.57% | +75.25% | 1.77 B USD | ||
| 2023 | ZYME Zymeworks Inc. - Common Stock | 26.04 USD | +5.13% | +3.25% | -0.50% | +46.79% | 1.85 B USD | ||
| 2035 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.22 USD | +1.33% | -2.55% | -19.55% | +14.21% | 1.74 B USD | ||
| 2042 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.88 USD | +5.04% | -3.78% | -0.86% | +102.35% | 1.79 B USD |